Istanbul Medeniyet University Medical Faculty

Istanbul 34722

0 studies enrolling now · 5 studies all time

What they study most

Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer, HER2-Positive Primary Breast Cancer, Juvenile Idiopathic Arthritis, Metastatic Head and Neck Cancer, Metastatic Non Small Cell Lung Cancer, Recurrent Head and Neck Cancer, Residual Invasive Breast Cancer, Unresectable Head and Neck Squamous Cell Carcinoma

Studies at this site

• A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1 — Recruiting now
• Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07) — Running, not enrolling
• A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05) — Running, not enrolling
• A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer — Running, not enrolling
• Efficacy Study Of Tofacitinib In Pediatric JIA Population — Completed